Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020 (Related Reports)

Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020


February 29, 2012
438 Pages - SKU: GBDT3865603
License type:
Online Download      US $6,995.00
Global Site License      US $20,985.00
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide
4/1/2014 | published by: Renub Research
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide Cervical Cancer Test Market Overview Cervical cancer is one of the deadliest cancers  |  read more...
$1,490.00
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 provides data on the B-Cell Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H1, 2014 provides data on the Lymphoblastic Lymphoma clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014 provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 provides data on the Non-Small Cell Lung Cancer clinical trial scenario. This  |  read more...
$2,500.00
Menopausal Hot Flashes - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Menopausal Hot Flashes - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Menopausal Hot Flashes - Pipeline Review, H1 2014’, provides an overview of the Menopausal Hot Flashes’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
$2,000.00
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant
4/14/2014 | published by: GBI Research
Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma  |  read more...
$3,500.00
Mast Cell Leukemia Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Mast Cell Leukemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mast Cell Leukemia Global Clinical Trials Review, H1, 2014 provides data on the Mast Cell Leukemia clinical trial scenario. This report provides elemental  |  read more...
$2,500.00
Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014 provides data on the Neuroendocrine Cancer clinical trial scenario. This report provides elemental information and data  |  read more...
$2,500.00
Colon Carcinoma - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
Colon Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colon Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Colon Carcinoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Colon  |  read more...
$2,000.00